Ibrahim Maattallaoui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ibrahim Maattallaoui has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Noureddine El Aouad
Research Team on Natural Products Chemistry and Smart Technologies (NPC-ST), Polydisciplinary Faculty of Larache, University Abdelmalek Essaadi, Tetouan 93000, Morocco
2 shared publications - Abdellah Maatallaoui
Laboratory of Advanced Science and Technologies, Polydisciplinary Faculty—Larache (FPL), Abdelmalek Essaadi University, Tetouan 92000, Morocco
1 shared publication - Ahlem Hamdache
Plant, Microbial, Marine, and Precision Agriculture Biotechnology research team, Laboratory of Natural and Economic Resources for Sustainable Development, Department of Life Sciences, Polydisciplinary Faculty of Larache (FPL), Abdelmalek Essaâdi University, Tetouan, Morocco
1 shared publication - Ahmed Bagayou
Plant, Microbial, Marine, and Precision Agriculture Biotechnology research team, Laboratory of Natural and Economic Resources for Sustainable Development, Department of Life Sciences, Polydisciplinary Faculty of Larache (FPL), Abdelmalek Essaâdi University, Tetouan, Morocco
1 shared publication - Enrique Barrajón-Catalán
Institute of Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Universitas Miguel Hernández (UMH), 03202 Elche, Spain
1 shared publication - Hicham El Bourki
Plant, Microbial, Marine, and Precision Agriculture Biotechnology research team, Laboratory of Natural and Economic Resources for Sustainable Development, Department of Life Sciences, Polydisciplinary Faculty of Larache (FPL), Abdelmalek Essaâdi University, Tetouan, Morocco
1 shared publication
Latest Publications
- Open Access
- 16 October 2026
- Published by MDPI AG in Chemistry Proceedings
- Vol. 22 (1) , 23
Development, Validation, and Application of a Structure-Based Pharmacophore Model for Human Dihydrofolate Reductase Inhibitor Discovery Through Drug Repurposing
Human dihydrofolate reductase (hDHFR) is a key enzyme in folate metabolism and an established therapeutic target in cancer and other diseases. Methotrexate (MTX), a clinically used hDHFR inhibitor, is effective but associated with toxicity and resistance, highlighting the need for alternative inhibitors. Here, we developed and validated a structure-based pharmacophore model derived from the hDHFR–MTX crystal complex and applied it to DrugBank for drug repurposing. Pharmacophore screening, Lipinski filtering, molecular docking, GNINA CNN scoring, and protein–ligand interaction analysis were integrated to prioritize potential hDHFR-targeting drugs. Ertugliflozin emerged as a promising computational candidate, warranting further molecular dynamics and experimental validation.
- 16 October 2026
- Published by MDPI AG in Chemistry Proceedings
- Vol. 22 (1) , 23
Open AccessDevelopment, Validation, and Application of a Structure-Based Pharmacophore Model for Human Dihydrofolate Reductase Inhibitor Discovery Through Drug Repurposing
Human dihydrofolate reductase (hDHFR) is a key enzyme in folate metabolism and an established therapeutic target in cancer and other diseases. Methotrexate (MTX), a clinically used hDHFR inhibitor, is effective but associated with toxicity and resistance, highlighting the need for alternative inhibitors. Here, we developed and validated a structure-based pharmacophore model derived from the hDHFR–MTX crystal complex and applied it to DrugBank for drug repurposing. Pharmacophore screening, Lipinski filtering, molecular docking, GNINA CNN scoring, and protein–ligand interaction analysis were integrated to prioritize potential hDHFR-targeting drugs. Ertugliflozin emerged as a promising computational candidate, warranting further molecular dynamics and experimental validation.
- 15 October 2026
- Published by Springer Nature in Water, Air, & Soil Pollution
- Vol. 237 (24) , 1388
Chlorpyrifos-Ethyl Contamination in Agricultural Soils and Earthworms: Field Monitoring, Complementary QSAR-Based Prediction, Bioaccumulation, and Ecological Risk Assessment in Intensive Potato Agroecosystems of Larache Province, Northern Morocco
- 15 October 2026
- Published by Springer Nature in Water, Air, & Soil Pollution
- Vol. 237 (24) , 1388
Chlorpyrifos-Ethyl Contamination in Agricultural Soils and Earthworms: Field Monitoring, Complementary QSAR-Based Prediction, Bioaccumulation, and Ecological Risk Assessment in Intensive Potato Agroecosystems of Larache Province, Northern Morocco
- Open Access
Development of QSAR Models and Web Applications for Predicting hDHFR Inhibitor Bioactivity Using Machine Learning
Human dihydrofolate reductase (hDHFR) is a crucial cellular enzyme in folate metabolic pathway, where it catalyzes the reduction of dihydrofolate into tetrahydrofolate (THF) and an important cofactor involved in DNA, RNA, protein biosynthesis and cell proliferation. Due to its importance, hDHFR has become a promising target for therapeutic development, particularly in treating cancer, bacterial infections, and autoimmune diseases. Its inhibition has found clinical value in antitumor, antimicrobial and antiprotozoal treatment; however, the emergence of resistance to existing hDHFR inhibitors necessitates the development of new and more potent compounds. In the current study, we propose a cheminformatics-based approach using machine learning to develop predictive models of hDHFR bioactivity. We used three types of molecular descriptors in the form of fingerprints, i.e., PubChem, Substructure, and MACCS, to capture structural properties associated with hDHFR inhibition. Predictive models were built using a random forest algorithm optimized through hyperparameter tuning. Feature selection was performed using Recursive Feature Elimination (RFE), and dataset dimensionality was reduced by removing outliers through Principal Component Analysis (PCA) to optimize model performance and reducing overfitting and weak predictivity. The resulting models are validated through external test sets, domain applicability analysis, and interpretation of influential molecular features via random forest feature importance selection plots and correlation matrix analysis. All three models exhibited strong predictive capabilities, with R-squared (R2) values ranging from 0.9849 to 0.9934 for the training set and 0.9381 to 0.9591 for the test set. These final predictive models were further incorporated into an accessible web application, enabling users to estimate the bioactivity of new compounds targeting hDHFR.
Open AccessDevelopment of QSAR Models and Web Applications for Predicting hDHFR Inhibitor Bioactivity Using Machine Learning
Human dihydrofolate reductase (hDHFR) is a crucial cellular enzyme in folate metabolic pathway, where it catalyzes the reduction of dihydrofolate into tetrahydrofolate (THF) and an important cofactor involved in DNA, RNA, protein biosynthesis and cell proliferation. Due to its importance, hDHFR has become a promising target for therapeutic development, particularly in treating cancer, bacterial infections, and autoimmune diseases. Its inhibition has found clinical value in antitumor, antimicrobial and antiprotozoal treatment; however, the emergence of resistance to existing hDHFR inhibitors necessitates the development of new and more potent compounds. In the current study, we propose a cheminformatics-based approach using machine learning to develop predictive models of hDHFR bioactivity. We used three types of molecular descriptors in the form of fingerprints, i.e., PubChem, Substructure, and MACCS, to capture structural properties associated with hDHFR inhibition. Predictive models were built using a random forest algorithm optimized through hyperparameter tuning. Feature selection was performed using Recursive Feature Elimination (RFE), and dataset dimensionality was reduced by removing outliers through Principal Component Analysis (PCA) to optimize model performance and reducing overfitting and weak predictivity. The resulting models are validated through external test sets, domain applicability analysis, and interpretation of influential molecular features via random forest feature importance selection plots and correlation matrix analysis. All three models exhibited strong predictive capabilities, with R-squared (R2) values ranging from 0.9849 to 0.9934 for the training set and 0.9381 to 0.9591 for the test set. These final predictive models were further incorporated into an accessible web application, enabling users to estimate the bioactivity of new compounds targeting hDHFR.